FXR activation by its agonists promotes the browning of adipose tissue, induces thermogenesis, and reduces diet-induced obesity and insulin resistance (Fang et al., 2015). The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.